Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
F Zhang, Y Ma, D Li, J Wei, K Chen, E Zhang… - Journal of Hematology & …, 2024 - Springer
Metabolic reprogramming provides tumors with an energy source and biofuel to support
their survival in the malignant microenvironment. Extensive research into the intrinsic …
their survival in the malignant microenvironment. Extensive research into the intrinsic …
[HTML][HTML] A systematic review of metabolomic profiling of gastric cancer and esophageal cancer
S Huang, Y Guo, Z Li, Y Zhang, T Zhou… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
Objective: Upper gastrointestinal (UGI) cancers, predominantly gastric cancer (GC) and
esophageal cancer (EC), are malignant tumor types with high morbidity and mortality rates …
esophageal cancer (EC), are malignant tumor types with high morbidity and mortality rates …
Nonhormonal therapy for endometriosis based on energy metabolism regulation
H Kobayashi, H Shigetomi… - Reproduction and …, 2021 - raf.bioscientifica.com
Ovarian function suppression is the current pharmacotherapy of endometriosis with limited
benefit and adverse effects. New therapeutic strategies other than hormonal therapy are …
benefit and adverse effects. New therapeutic strategies other than hormonal therapy are …
Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo
LY Fong, K Huebner, R **g… - Proceedings of the …, 2023 - National Acad Sciences
Esophageal squamous cell carcinoma (ESCC) is a deadly disease with few prevention or
treatment options. ESCC development in humans and rodents is associated with Zn …
treatment options. ESCC development in humans and rodents is associated with Zn …
Serum metabolomics for biomarker screening of esophageal squamous cell carcinoma and esophageal squamous dysplasia using gas chromatography-mass …
S Zhang, X Lu, C Hu, Y Li, H Yang, H Yan, J Fan… - ACS …, 2020 - ACS Publications
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common
malignancies with poor diagnosis. Esophageal squamous dysplasia (ESD) is considered as …
malignancies with poor diagnosis. Esophageal squamous dysplasia (ESD) is considered as …
New metabolic alterations and a predictive marker pipecolic acid in sera for esophageal squamous cell carcinoma
L Liu, J Wu, M Shi, F Wang, H Lu, J Liu… - Genomics …, 2022 - academic.oup.com
Esophageal squamous cell carcinoma (ESCC) is a major histological subtype of
esophageal cancer with a poor prognosis. Although several serum metabolomic …
esophageal cancer with a poor prognosis. Although several serum metabolomic …
Plasma metabolomics identifies lipid and amino acid markers of weight loss in patients with upper gastrointestinal cancer
J Miller, A Alshehri, MI Ramage, NA Stephens… - Cancers, 2019 - mdpi.com
Cachexia is a multifactorial wasting syndrome associated with high morbidity and mortality
in patients with cancer. Diagnosis can be difficult and, in the clinical situation, usually relies …
in patients with cancer. Diagnosis can be difficult and, in the clinical situation, usually relies …
Metabolomic characterization reveals ILF2 and ILF3 affected metabolic adaptions in esophageal squamous cell carcinoma
B Zang, W Wang, Y Wang, P Li, T ** countries. Patients with advanced ESCC have a poor prognosis and survival …